Form 4: OptimizeRx CCO Disposes Shares for Tax Obligations

OptimizeRx Chief Commercial Officer Theresa Greco disposed of 1,420 shares of common stock to cover tax withholding obligations related to restricted stock unit vesting.

Summary

• Theresa Greco, Chief Commercial Officer of OptimizeRx Corp (OPRX), reported a disposition of common stock.
• The transaction involved 1,420 shares of OptimizeRx common stock.
• The shares were disposed of at a price of $12.74 per share.
• The disposition occurred on December 23, 2025.
• The shares were withheld by OptimizeRx to satisfy tax withholding obligations upon the vesting of restricted stock units.
• Following this transaction, Theresa Greco beneficially owns 72,868 shares of OptimizeRx common stock directly.

Sentiment

Score: 5

Explanation: The filing reports a routine, non-discretionary disposition of shares for tax withholding purposes upon restricted stock unit vesting, which is a neutral event and does not indicate positive or negative sentiment regarding the company's performance or outlook.

Future Outlook

This filing does not contain any forward-looking statements or guidance.

Industry Context

This is a routine insider transaction filing (Form 4) reporting a non-discretionary disposition of shares for tax purposes, which is a common occurrence across all publicly traded companies when restricted stock units vest for executives.

Stakeholder Impact

• Shareholders: Minimal impact as this is a routine, non-discretionary transaction for tax purposes and not a market sale.

Key Dates

Keywords

OptimizeRx, OPRX, Insider Transaction, Form 4, Stock Disposition, Tax Withholding, Restricted Stock Units, Theresa Greco